Skip to content (Press Enter)
A natural history study in LGMD2i, “Biomarker Development in LGMD 2i”, is now open to enrollment. This study will be collecting data for an upcoming oral treatment study with ML Bio Solutions. For more information on the study and how to participate, please contact Brittney Holmberg at Brittney.Holmberg@vcuhealth.org or 804-552-0014. Here is the latest press release.
PTC Therapeutics clinical trial with Emflaza is now open!
Ask Bio will be starting a gene therapy trial for LGMD2i late summer/early fall of 2020!
